References
- Accuracy of the references is the responsibility of the author.
- Kinsella J. Covering the plague: AIDS and the American media. New Brunswick, NJ: Rutgers University Press, 1989
- Nielsen BP, Gallegos DA, Harris DL, et al. AIDS awareness among rural Utah physicians. West J Med 1991: 154(Jun): 689–92
- Gerbert B, Maguire BT, Bleecker T, et al. Primary care physicians and AIDS: attitudinal and structural barriers to care. JAMA 1991: 266(20): 2837–42
- Barre-Sinoussi F, Cherman JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983: 220: 868–71
- Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984: 224: 500–3
- Levy JA, Hoffman AD, Kramer SM, et al. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 1984: 225: 840–2
- Sarngadharan MG, Popovic M, Bruch L, et al. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984: 224: 506–8
- Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989: 38(S-7): 1–7
- Jackson JB, MacDonald KL, Cadwell J, et al. Absence of HIV infection in blood donors with indeterminate Western blot tests for antibody to HIV-1. N Engl J Med 1990: 322(4): 217–22
- Sloand EM, Pitt E, Chiarello RJ, et al. HIV testing: state of the art. JAMA 1991: 266 (20): 2861–6
- Phair J, Muñoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 1990: 322(3): 161–5
- Landesman S, Minkoff H, Holman S, et al. Serosurvey of human immunodeficiency virus infection in parturients: implications for human immunodeficiency virus testing programs of pregnant women. JAMA 1987: 258 (19): 2701–3
- Cochran SD, Mays VM. Sex, lies, and HIV. (Letter) N Engl J Med 1990: 322: 774
- Higgins DL, Galavotti Q O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA1991: 266(17): 2419–29
- Lifson AR, Rutherford GW, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis 1988: 158: 1360–7
- Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11-year follow up study. Br Med J 1990: 301: 1183–8
- Kuo JM, Taylor JMG, Detels R. Estimating the AIDS incubation period from a prevalent cohort. Am J Epidemiol 1991: 133(10): 1050–7
- Greatbatch W, Holmes W. Blood transfusion and AIDS in the USA. J R Soc Health 1991: (Aug): 123–5
- Moore RD, Hidalgo J, Sugland BW, et al. Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med 1991: 324(May 16): 1412–6
- Lemp GF, Payne SF, Neal D, et al. Survival trends for patients with AIDS. JAMA 1990: 263(3): 402–6
- Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trial. Ann Intern Med 1990: 112: 727–37
- Volberding PA, Lagakos SW Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990: 322(14): 941–9
- Masur H, Ognibene FP, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med 1989: 111(3): 223–231
- Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989: 38 (S-5): 1–8
- Henry K, Thurn J. The evolving challenge of Pneumocystis carinii: a deadly opportunist in AIDS. Postgrad Med 1990: 87(2): 45–56
- Centers for Disease Control. Update: transmission of HIV infection during invasive dental procedures—Florida. MMWR 1991: 40(23): 377–81
- Bell DM. Human immunodeficiency virus transmission in health care settings: risk and risk reduction. Am J Med 1991: 91(Suppl 3B): 294–300
- Gerberding JL. Reducing occupational risk of HIV infection. Hosp Pract 1991: 26(Jun 15): 103–118
- Henderson DK. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus type 1: current status and prospects for the future. Am J Med 1991: 91(Suppl 3B): 312–9
- Henry K, Thurn J. HIV infection in healthcare workers: How great is the risk? What can be done before and after exposure? Postgrad Med 1991: 89(3): 30–8
- Bruhn JG. What to say to persons with HIV disease. South Med J 1991: 84(12): 1430–4
- Ferguson KJ, Stapleton JT, Helms CM. Physicians' effectivenesss in assessing risk for human immunodeficiency virus infection. Arch Intern Med 1991: 151(Mar): 561–4
- Fleisher JM, Minkoff HL, Senie BT, et al. Assessing prior history of sexually transmitted disease. (Letter) JAMA 1991: 266(12): 1646